Vedanta is playing catch-up with VE303, as a rival microbiome therapy from Seres Therapeutics, called Vowst, has been ...

Following the first-ever FDA approval of a TIL therapy in the U.S., and with regulatory decisions pending in Canada and ...

Returning for its third year, the Donor Selection & Cell Source Summit is the only industry-dedicated forum focused ...

Improved patient outcomes and safety: Ultimately, smarter learning powered by AI should lead to better care. More ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its ...

Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...

Boehringer Ingelheim and Zealand Pharma have kicked off three phase 3 trials of obesity drug candidate survodutide, in patients with and without diabetes, in the hope of breaking into a market ...

LEAP TA: Life Sciences is the only event entirely dedicated to transforming how biotech and pharma organizations are ...

The 9th MASH Drug Development Summit is the essential forum for pharmaceutical giants and innovative biotechs dedicated to ...

At Axtria Ignite 2025 in Princeton, New Jersey, editor-in-chief Jonah Comstock connected with GSK's SVP of enterprise AI and chief digital and technology officer, commercial, Madhavi Ramakrishna.

After more than a decade of digital transformation, pharmaceutical marketing is on the cusp of achieving what the industry ...

With ongoing clinical trials and promising early data, tegoprubart may soon redefine the standard of care in transplantation ...